Explaining the Variability of Biologics and Biosimilars

Jim M. Koeller, MS, FHOPA, discusses the inherent variability of recombinant DNA technology behind biosimilars.

Website:
Twitter:
Facebook:
LinkedIn:

cancer,oncology,